With respect, the EHR related posts should be kept to the EHR forum. I note some jealousy regarding investor attention on HRL - I am sure EHR will have its day(s) in the sun and is an interesting story but I don't think it is particularly helpful in comparing them against each other as they both offer different investment opportunities.
Roadshow in Perth finished on Thursday with good interest shown. Monday week New Zealand, then back to eastern states for more presentations to brokers and funds who want to hear the story and missed out on the first pass. This will be followed up by roadshow in Asia and I have heard interest now being shown in London.
I believe there is also opportunity to tap into North American and South American investing community. Very interesting times ahead. Would not be surprised to see this story written up soon! Lots happening over March.
HRL Price at posting:
7.5¢ Sentiment: Buy Disclosure: Held